Do analysts rate DHAC or VSEE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Digital Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 VSee Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, DHAC or VSEE?

Digital Health Acquisition has higher earnings, but lower revenue than VSee Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Digital Health Acquisition N/A N/A N/A N/A N/A VSee Health $14.62M N/A -$14.71M -$0.54 N/A

Do analysts prefer NIVF or DHAC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewGenIvf Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Digital Health Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, NIVF or DHAC?

NewGenIvf Group has higher revenue and earnings than Digital Health Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NewGenIvf Group $4.73M 0.03 $9.88M N/A N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Is NIVF or DHAC more profitable?

Company Net Margins Return on Equity Return on Assets NewGenIvf Group N/A N/A N/A Digital Health Acquisition N/A N/A N/A

Which has preferable earnings & valuation, BACK or DHAC?

Digital Health Acquisition has lower revenue, but higher earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $72.05K 2.10 -$9.42M -$3.12 N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Is BACK or DHAC more profitable?

Company Net Margins Return on Equity Return on Assets IMAC N/A N/A -325.44% Digital Health Acquisition N/A N/A N/A

Which has preferable earnings & valuation, BTTX or DHAC?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Better Therapeutics N/A N/A -$39.76M -$0.78 N/A Digital Health Acquisition N/A N/A N/A N/A N/A

Is BTTX or DHAC more profitable?

Company Net Margins Return on Equity Return on Assets Better Therapeutics N/A N/A N/A Digital Health Acquisition N/A N/A N/A

Which has better earnings and valuation, UPHL or DHAC?

Digital Health Acquisition has lower revenue, but higher earnings than UpHealth. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio UpHealth $130M 0.00 -$56.42M $1.47 0.00 Digital Health Acquisition N/A N/A N/A N/A N/A

Is UPHL or DHAC more profitable?

Company Net Margins Return on Equity Return on Assets UpHealth N/A N/A N/A Digital Health Acquisition N/A N/A N/A

Digital Health Acquisition (DHAC) Competitors

$0.14 -0.01 (-8.97%)

As of 06/12/2026

Compare

DHAC vs. VSEE, NIVF, BACK, BTTX, and UPHL

Should you buy Digital Health Acquisition stock or one of its competitors? MarketBeat compares Digital Health Acquisition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Digital Health Acquisition include VSee Health (VSEE), NewGenIvf Group (NIVF), IMAC (BACK), Better Therapeutics (BTTX), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

How does Digital Health Acquisition compare to VSee Health?

Digital Health Acquisition (NASDAQ:DHAC) and VSee Health (NASDAQ:VSEE) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

In the previous week, VSee Health had 4 more articles in the media than Digital Health Acquisition. MarketBeat recorded 4 mentions for VSee Health and 0 mentions for Digital Health Acquisition. VSee Health's average media sentiment score of 0.72 beat Digital Health Acquisition's score of 0.00 indicating that VSee Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Digital Health Acquisition	Neutral
VSee Health	Positive

1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 1.0% of VSee Health shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by insiders. Comparatively, 19.7% of VSee Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Digital Health Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
VSee Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Digital Health Acquisition has a net margin of 0.00% compared to VSee Health's net margin of -92.36%. Digital Health Acquisition's return on equity of 0.00% beat VSee Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Digital Health Acquisition	N/A	N/A	N/A
VSee Health	-92.36%	-11,636.34%	-68.62%

Digital Health Acquisition has higher earnings, but lower revenue than VSee Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A
VSee Health	$14.62M	N/A	-$14.71M	-$0.54	N/A

Summary

VSee Health beats Digital Health Acquisition on 6 of the 9 factors compared between the two stocks.

How does Digital Health Acquisition compare to NewGenIvf Group?

NewGenIvf Group (NASDAQ:NIVF) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

In the previous week, NewGenIvf Group had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Digital Health Acquisition. NewGenIvf Group's average media sentiment score of 1.21 beat Digital Health Acquisition's score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the media.

Company	Overall Sentiment
NewGenIvf Group	Positive
Digital Health Acquisition	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Digital Health Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

NewGenIvf Group has higher revenue and earnings than Digital Health Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.03	$9.88M	N/A	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Digital Health Acquisition	N/A	N/A	N/A

NewGenIvf Group has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Digital Health Acquisition has a beta of 0.23, suggesting that its stock price is 77% less volatile than the broader market.

Summary

NewGenIvf Group beats Digital Health Acquisition on 6 of the 7 factors compared between the two stocks.

How does Digital Health Acquisition compare to IMAC?

IMAC (NASDAQ:BACK) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

5.8% of IMAC shares are owned by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are owned by institutional investors. 12.3% of IMAC shares are owned by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

IMAC has a beta of 1.71, indicating that its stock price is 71% more volatile than the broader market. Comparatively, Digital Health Acquisition has a beta of 0.23, indicating that its stock price is 77% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	N/A	N/A	-325.44%
Digital Health Acquisition	N/A	N/A	N/A

Digital Health Acquisition has lower revenue, but higher earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$72.05K	2.10	-$9.42M	-$3.12	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

In the previous week, IMAC's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company	Overall Sentiment
IMAC	Neutral
Digital Health Acquisition	Neutral

Summary

IMAC beats Digital Health Acquisition on 4 of the 5 factors compared between the two stocks.

How does Digital Health Acquisition compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Better Therapeutics	N/A	N/A	-$39.76M	-$0.78	N/A
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Better Therapeutics	N/A	N/A	N/A
Digital Health Acquisition	N/A	N/A	N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company	Overall Sentiment
Better Therapeutics	Neutral
Digital Health Acquisition	Neutral

Better Therapeutics has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, Digital Health Acquisition has a beta of 0.23, indicating that its stock price is 77% less volatile than the broader market.

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Better Therapeutics beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does Digital Health Acquisition compare to UpHealth?

UpHealth (NYSE:UPHL) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

56.1% of UpHealth shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
UpHealth	N/A	N/A	N/A
Digital Health Acquisition	N/A	N/A	N/A

UpHealth has a beta of 0.5, meaning that its share price is 50% less volatile than the broader market. Comparatively, Digital Health Acquisition has a beta of 0.23, meaning that its share price is 77% less volatile than the broader market.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company	Overall Sentiment
UpHealth	Neutral
Digital Health Acquisition	Neutral

Digital Health Acquisition has lower revenue, but higher earnings than UpHealth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
UpHealth	$130M	0.00	-$56.42M	$1.47	0.00
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

UpHealth beats Digital Health Acquisition on 4 of the 4 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DHAC vs. The Competition

Export

Metric	Digital Health Acquisition	Holding Offices Industry	Services Sector	NASDAQ Exchange
Market Cap	$512K	$256.17M	$962.91M	$12.05B
Dividend Yield	N/A	3.09%	4.70%	5.66%
P/E Ratio	N/A	2.32	11.03	24.42
Price / Sales	N/A	0.14	42.48	118.72
Price / Cash	N/A	127.58	55.62	37.92
Price / Book	N/A	28.95	11.34	6.82
Net Income	N/A	-$9.51M	-$12.34M	$337.56M
7 Day Performance	-10.69%	14.41%	6.74%	1.16%
1 Month Performance	-21.55%	15.56%	2.59%	3.16%
1 Year Performance	-85.94%	14.44%	97.26%	30.60%

Digital Health Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DHAC Digital Health Acquisition	N/A	$0.14 -9.0%	N/A	-85.9%	$512K	N/A	N/A	2,021	Gap Down High Trading Volume
VSEE VSee Health	0.2408 of 5 stars	$0.18 -6.8%	N/A	-85.9%	$676K	$14.46M	N/A	N/A	Short Interest Increase Gap Up High Trading Volume
NIVF NewGenIvf Group	2.2452 of 5 stars	$0.93 -2.6%	N/A	-99.9%	$224K	$4.73M	N/A	N/A	Gap Down
BACK IMAC	N/A	$0.04 -11.1%	N/A	-5.9%	$170K	$72.05K	N/A	180
BTTX Better Therapeutics	N/A	$0.00 flat	N/A	N/A	$4K	N/A	N/A	40	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DHAC) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Digital Health Acquisition (DHAC) Competitors

DHAC vs. VSEE, NIVF, BACK, BTTX, and UPHL

How does Digital Health Acquisition compare to VSee Health?

Summary

How does Digital Health Acquisition compare to NewGenIvf Group?

Summary

How does Digital Health Acquisition compare to IMAC?

Summary

How does Digital Health Acquisition compare to Better Therapeutics?

Summary

How does Digital Health Acquisition compare to UpHealth?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHAC vs. The Competition

Digital Health Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Digital Health Acquisition (DHAC) Competitors

DHAC vs. VSEE, NIVF, BACK, BTTX, and UPHL

How does Digital Health Acquisition compare to VSee Health?

Does the media prefer DHAC or VSEE?

Do insiders & institutionals hold more shares of DHAC or VSEE?

Do analysts rate DHAC or VSEE?

Is DHAC or VSEE more profitable?

Which has stronger earnings and valuation, DHAC or VSEE?

Summary

How does Digital Health Acquisition compare to NewGenIvf Group?

Does the media prefer NIVF or DHAC?

Do analysts prefer NIVF or DHAC?

Which has better valuation and earnings, NIVF or DHAC?

Do insiders and institutionals believe in NIVF or DHAC?

Is NIVF or DHAC more profitable?

Which has more volatility and risk, NIVF or DHAC?

Summary

How does Digital Health Acquisition compare to IMAC?

Do insiders & institutionals believe in BACK or DHAC?

Which has more volatility and risk, BACK or DHAC?

Is BACK or DHAC more profitable?

Which has preferable earnings & valuation, BACK or DHAC?

Does the media favor BACK or DHAC?

Summary

How does Digital Health Acquisition compare to Better Therapeutics?

Which has preferable earnings & valuation, BTTX or DHAC?

Is BTTX or DHAC more profitable?

Does the media favor BTTX or DHAC?

Which has more volatility and risk, BTTX or DHAC?

Do insiders & institutionals believe in BTTX or DHAC?

Summary

How does Digital Health Acquisition compare to UpHealth?

Do insiders & institutionals have more ownership in UPHL or DHAC?

Is UPHL or DHAC more profitable?

Which has more risk & volatility, UPHL or DHAC?

Does the media prefer UPHL or DHAC?

Which has better earnings and valuation, UPHL or DHAC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DHAC vs. The Competition

Digital Health Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools